The Impact of a Comprehensive Risk Prediction Model for Colorectal Cancer on a Population Screening Program

被引:7
作者
Saya, Sibel [1 ,2 ]
Emery, Jon D. [1 ,2 ]
Dowty, James G. [3 ]
McIntosh, Jennifer G. [1 ,2 ]
Winship, Ingrid M. [4 ,5 ]
Jenkins, Mark A. [3 ]
机构
[1] Univ Melbourne, Fac Med Dent & Hlth Sci, Dept Gen Practice, Melbourne, Vic 3010, Australia
[2] Univ Melbourne, Fac Med Dent & Hlth Sci, Ctr Canc Res, Melbourne, Vic 3010, Australia
[3] Univ Melbourne, Ctr Epidemiol & Biostat, Melbourne Sch Populat & Global Hlth, Melbourne, Vic, Australia
[4] Royal Melbourne Hosp, Genom Med & Family Canc Clin, Melbourne, Vic, Australia
[5] Univ Melbourne, Fac Med Dent & Hlth Sci, Dept Med, Melbourne, Vic, Australia
基金
美国国家卫生研究院; 英国医学研究理事会;
关键词
GENOME-WIDE ASSOCIATION; SINGLE NUCLEOTIDE POLYMORPHISMS; POLYGENIC RISK; SUSCEPTIBILITY LOCI; GENERAL-PRACTICE; GENETIC RISK; BREAST; PREVENTION; GUIDELINES; WOMEN;
D O I
10.1093/jncics/pkaa062
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: In many countries, population colorectal cancer (CRC) screening is based on age and family history, though more precise risk prediction could better target screening. We examined the impact of a CRC risk prediction model (incorporating age, sex, lifestyle, genomic, and family history factors) to target screening under several feasible screening scenarios. Methods: We estimated the model's predicted CRC risk distribution in the Australian population. Predicted CRC risks were categorized into screening recommendations under 3 proposed scenarios to compare with current recommendations: 1) highly tailored, 2) 3 risk categories, and 3) 4 sex-specific risk categories. Under each scenario, for 35- to 74-year-olds, we calculated the number of CRC screens by immunochemical fecal occult blood testing (iFOBT) and colonoscopy and the proportion of predicted CRCs over 10 years in each screening group. Results: Currently, 1.1% of 35- to 74-yearolds are recommended screening colonoscopy and 56.2% iFOBT, and 5.7% and 83.2% of CRCs over 10 years were predicted to occur in these groups, respectively. For the scenarios, 1) colonoscopy was recommended to 8.1% and iFOBT to 37.5%, with 36.1% and 50.1% of CRCs in each group; 2) colonoscopy was recommended to 2.4% and iFOBT to 56.0%, with 13.2% and 76.9% of cancers in each group; and 3) colonoscopy was recommended to 5.0% and iFOBT to 54.2%, with 24.5% and 66.5% of cancers in each group. Conclusions: A highly tailored CRC screening scenario results in many fewer screens but more cancers in those unscreened. Category-based scenarios may provide a good balance between number of screens and cancers detected and are simpler to implement.
引用
收藏
页数:7
相关论文
共 56 条
[21]   Determining Risk of Colorectal Cancer and Starting Age of Screening Based on Lifestyle, Environmental, and Genetic Factors [J].
Jeon, Jihyoun ;
Du, Mengmeng ;
Schoen, Robert E. ;
Hoffmeister, Michael ;
Newcomb, Polly A. ;
Berndt, Sonja I. ;
Caan, Bette ;
Campbell, Peter T. ;
Chan, Andrew T. ;
Chang-Claude, Jenny ;
Giles, Graham G. ;
Gong, Jian ;
Harrison, Tabitha A. ;
Huyghe, Jeroen R. ;
Jacobs, Eric J. ;
Li, Li ;
Lin, Yi ;
Le Marchand, Loic ;
Potter, John D. ;
Qu, Conghui ;
Bien, Stephanie A. ;
Zubair, Niha ;
Macinnis, Robert J. ;
Buchanan, Daniel D. ;
Hopper, John L. ;
Cao, Yin ;
Nishihara, Reiko ;
Rennert, Gad ;
Slattery, Martha L. ;
Thomas, Duncan C. ;
Woods, Michael O. ;
Prentice, Ross L. ;
Gruber, Stephen B. ;
Zheng, Yingye ;
Brenner, Hermann ;
Hayes, Richard B. ;
White, Emily ;
Peters, Ulrike ;
Hsu, Li .
GASTROENTEROLOGY, 2018, 154 (08) :2152-+
[22]   Public interest in and acceptability of the prospect of risk-stratified screening for breast and prostate cancer [J].
Koitsalu, Marie ;
Sprangers, Mirjam A. G. ;
Eklund, Martin ;
Czene, Kamila ;
Hall, Per ;
Gronberg, Henrik ;
Brandberg, Yvonne .
ACTA ONCOLOGICA, 2016, 55 (01) :45-51
[23]   Effects of Organized Colorectal Cancer Screening on Cancer Incidence and Mortality in a Large Community-Based Population [J].
Levin, Theodore R. ;
Corley, Douglas A. ;
Jensen, Christopher D. ;
Schottinger, Joanne E. ;
Quinn, Virginia P. ;
Zauber, Ann G. ;
Lee, Jeffrey K. ;
Zhao, Wei K. ;
Udaltsova, Natalia ;
Ghai, Nirupa R. ;
Lee, Alexander T. ;
Quesenberry, Charles P. ;
Fireman, Bruce H. ;
Doubeni, Chyke A. .
GASTROENTEROLOGY, 2018, 155 (05) :1383-+
[24]   Long-term evaluation of benefits, harms, and cost-effectiveness of the National Bowel Cancer Screening Program in Australia: a modelling study [J].
Lew, Jie-Bin ;
St John, D. James B. ;
Xu, Xiang-Ming ;
Greuter, Marjolein J. E. ;
Caruana, Michael ;
Cenin, Dayna R. ;
He, Emily ;
Saville, Marion ;
Grogan, Paul ;
Coupe, Veerle M. H. ;
Canfell, Karen .
LANCET PUBLIC HEALTH, 2017, 2 (07) :E331-E340
[25]   Large-Scale Genome-Wide Association Study of East Asians Identifies Loci Associated With Risk for Colorectal Cancer [J].
Lu, Yingchang ;
Kweon, Sun-Seog ;
Tanikawa, Chizu ;
Jia, Wei-Hua ;
Xiang, Yong-Bing ;
Cai, Qiuyin ;
Zeng, Chenjie ;
Schmit, Stephanie L. ;
Shin, Aesun ;
Matsuo, Keitaro ;
Jee, Sun Ha ;
Kim, Dong-Hyun ;
Kim, Jeongseon ;
Wen, Wanqing ;
Shi, Jiajun ;
Guo, Xingyi ;
Li, Bingshan ;
Wang, Nan ;
Zhang, Ben ;
Li, Xinxiang ;
Shin, Min-Ho ;
Li, Hong-Lan ;
Ren, Zefang ;
Oh, Jae Hwan ;
Oze, Isao ;
Ahn, Yoon-Ok ;
Jung, Keum Ji ;
Conti, David V. ;
Schumacher, Fredrick R. ;
Rennert, Gad ;
Jenkins, Mark A. ;
Campbell, Peter T. ;
Hoffmeister, Michael ;
Casey, Graham ;
Gruber, Stephen B. ;
Gao, Jing ;
Gao, Yu-Tang ;
Pan, Zhi-Zhong ;
Kamatani, Yoichiro ;
Zeng, Yi-Xin ;
Shu, Xiao-Ou ;
Long, Jirong ;
Matsuda, Koichi ;
Zheng, Wei .
GASTROENTEROLOGY, 2019, 156 (05) :1455-1466
[26]   Breast Cancer Risk From Modifiable and Nonmodifiable Risk Factors Among White Women in the United States [J].
Maas, Paige ;
Barrdahl, Myrto ;
Joshi, Amit D. ;
Auer, Paul L. ;
Gaudet, Mia M. ;
Milne, Roger L. ;
Schumacher, Fredrick R. ;
Anderson, William F. ;
Check, David ;
Chattopadhyay, Subham ;
Baglietto, Laura ;
Berg, Christine D. ;
Chanock, Stephen J. ;
Cox, David G. ;
Figueroa, Jonine D. ;
Gail, Mitchell H. ;
Graubard, Barry I. ;
Haiman, Christopher A. ;
Hankinson, Susan E. ;
Hoover, Robert N. ;
Isaacs, Claudine ;
Kolonel, Laurence N. ;
Le Marchand, Loic ;
Lee, I-Min ;
Lindstrom, Sara ;
Overvad, Kim ;
Romieu, Isabelle ;
Sanchez, Maria-Jose ;
Southey, Melissa C. ;
Stram, Daniel O. ;
Tumino, Rosario ;
VanderWeele, Tyler J. ;
Willett, Walter C. ;
Zhang, Shumin ;
Buring, Julie E. ;
Canzian, Federico ;
Gapstur, Susan M. ;
Henderson, Brian E. ;
Hunter, David J. ;
Giles, Graham G. ;
Prentice, Ross L. ;
Ziegler, Regina G. ;
Kraft, Peter ;
Garcia-Closas, Montse ;
Chatterjee, Nilanjan .
JAMA ONCOLOGY, 2016, 2 (10) :1295-1302
[27]   European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition Organisation [J].
Malila, N. ;
Senore, C. ;
Armaroli, P. .
ENDOSCOPY, 2012, 44 :SE31-SE48
[28]   Risk Prediction Models for Colorectal Cancer Incorporating Common Genetic Variants: A Systematic Review [J].
McGeoch, Luke ;
Saunders, Catherine L. ;
Griffin, Simon J. ;
Emery, Jon D. ;
Walter, Fiona M. ;
Thompson, Deborah J. ;
Antoniou, Antonis C. ;
Usher-Smith, Juliet A. .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2019, 28 (10) :1580-1593
[29]   Adjusting the frequency of mammography screening on the basis of genetic risk: Attitudes among women in the UK [J].
Meisel, Susanne F. ;
Pashayan, Nora ;
Rahman, Belinda ;
Side, Lucy ;
Fraser, Lindsay ;
Gessler, Sue ;
Lanceley, Anne ;
Wardle, Jane .
BREAST, 2015, 24 (03) :237-241
[30]   Primary-care providers' perceived barriers to integration of genetics services: a systematic review of the literature [J].
Mikat-Stevens, Natalie A. ;
Larson, Ingrid A. ;
Tarini, Beth A. .
GENETICS IN MEDICINE, 2015, 17 (03) :169-176